Form 4 for VOR Vor Biopharma Inc.
Accepted 2024-12-31 00:00:00 ET · period of report 2024-12-27 · accession 0001415889-24-030316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 2024-12-27 | VOR | Attar Eyal C. | Chief MEDICAL Off | S - Sale | $1.25 | -10.3K | 81.4K | -11% | -$12.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-27 | S | D | 10,334 | $1.25 | 81,439 | D | — | — |